Riccardo Autorino1,2, Pierluigi Bove3, Marco De Sio4, Roberto Miano3, Salvatore Micali5, Luca Cindolo6, Francesco Greco7, Jilian Nicholas8, Cristian Fiori9, Giampaolo Bianchi5, Fernando J Kim10, Francesco Porpiglia9. 1. University Hospitals Urology Institute, Case Medical Center, Cleveland, OH, USA. ricautor@gmail.com. 2. Urology Unit, Second University of Naples, Naples, Italy. ricautor@gmail.com. 3. Department of Urology, Tor Vergata University, Rome, Italy. 4. Urology Unit, Second University of Naples, Naples, Italy. 5. Department of Urology, University of Modena and Reggio Emilia, Modena, Italy. 6. Department of Urology, S. Pio da Pietrelcina Hospital, Vasto, Italy. 7. Department of Urology and Mini-Invasive Surgery, Romolo Hospital, Crotone, Italy. 8. University Hospitals Urology Institute, Case Medical Center, Cleveland, OH, USA. 9. Division of Urology, "San Luigi Gonzaga" Hospital University of Turin, Orbassano, Italy. 10. Division of Urology, Denver Health Medical Center, Denver, CO, USA.
Abstract
PURPOSE: This study was designed to determine the role of laparoscopic adrenalectomy (LA) in the surgical management of adrenocortical carcinoma (ACC). METHODS: A systematic literature review was performed on January 2, 2015 using PubMed. Article selection proceeded according to PRISMA criteria. Studies comparing open adrenalectomy (OA) to LA for ACC and including at least 10 cases per each surgical approach were included. Odds ratio (OR) was used for all binary variables, and weight mean difference (WMD) was used for the continuous parameters. Pooled estimates were calculated with the fixed-effect model, if no significant heterogeneity was identified; alternatively, the random-effect model was used when significant heterogeneity was detected. Main demographics, surgical outcomes, and oncological outcomes were analyzed. RESULTS: Nine studies published between 2010 and 2014 were deemed eligible and included in the analysis, all of them being retrospective case-control studies. Overall, they included 240 LA and 557 OA cases. Tumors treated with laparoscopy were significantly smaller in size (WMD -3.41 cm; confidence interval [CI] -4.91, -1.91; p < 0.001), and a higher proportion of them (80.8 %) more at a localized (I-II) stage compared with open surgery (67.7 %) (odds ratio [OR] 2.8; CI 1.8, 4.2; p < 0.001). Hospitalization time was in favor of laparoscopy, with a WMD of -2.5 days (CI -3.3, -1.7; p < 0.001). There was no difference in the overall recurrence rate between LA and OA (relative risk [RR] 1.09; CI 0.83, 1.43; p = 0.53), whereas development of peritoneal carcinomatosis was higher for LA (RR 2.39; CI 1.41, 4.04; p = 0.001). No difference could be found for time to recurrence (WMD -8.2 months; CI -18.2, 1.7; p = 0.11), as well as for cancer specific mortality (OR 0.68; CI 0.44, 1.05; p = 0.08). CONCLUSIONS: OA should still be considered the standard surgical management of ACC. LA can offer a shorter hospital stay and possibly a faster recovery. Therefore, this minimally invasive approach can certainly play a role in this setting, but it should be only offered in carefully selected cases to avoid jeopardizing the oncological outcome.
PURPOSE: This study was designed to determine the role of laparoscopic adrenalectomy (LA) in the surgical management of adrenocortical carcinoma (ACC). METHODS: A systematic literature review was performed on January 2, 2015 using PubMed. Article selection proceeded according to PRISMA criteria. Studies comparing open adrenalectomy (OA) to LA for ACC and including at least 10 cases per each surgical approach were included. Odds ratio (OR) was used for all binary variables, and weight mean difference (WMD) was used for the continuous parameters. Pooled estimates were calculated with the fixed-effect model, if no significant heterogeneity was identified; alternatively, the random-effect model was used when significant heterogeneity was detected. Main demographics, surgical outcomes, and oncological outcomes were analyzed. RESULTS: Nine studies published between 2010 and 2014 were deemed eligible and included in the analysis, all of them being retrospective case-control studies. Overall, they included 240 LA and 557 OA cases. Tumors treated with laparoscopy were significantly smaller in size (WMD -3.41 cm; confidence interval [CI] -4.91, -1.91; p < 0.001), and a higher proportion of them (80.8 %) more at a localized (I-II) stage compared with open surgery (67.7 %) (odds ratio [OR] 2.8; CI 1.8, 4.2; p < 0.001). Hospitalization time was in favor of laparoscopy, with a WMD of -2.5 days (CI -3.3, -1.7; p < 0.001). There was no difference in the overall recurrence rate between LA and OA (relative risk [RR] 1.09; CI 0.83, 1.43; p = 0.53), whereas development of peritoneal carcinomatosis was higher for LA (RR 2.39; CI 1.41, 4.04; p = 0.001). No difference could be found for time to recurrence (WMD -8.2 months; CI -18.2, 1.7; p = 0.11), as well as for cancer specific mortality (OR 0.68; CI 0.44, 1.05; p = 0.08). CONCLUSIONS: OA should still be considered the standard surgical management of ACC. LA can offer a shorter hospital stay and possibly a faster recovery. Therefore, this minimally invasive approach can certainly play a role in this setting, but it should be only offered in carefully selected cases to avoid jeopardizing the oncological outcome.
Authors: Patrick Heger; Pascal Probst; Felix J Hüttner; Käthe Gooßen; Tanja Proctor; Beat P Müller-Stich; Oliver Strobel; Markus W Büchler; Markus K Diener Journal: World J Surg Date: 2017-11 Impact factor: 3.352
Authors: Christina W Lee; Ahmed I Salem; David F Schneider; Glen E Leverson; Thuy B Tran; George A Poultsides; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Lawrence Shirley; Ryan C Fields; Linda X Jin; Timothy M Pawlik; Jason D Prescott; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Sharon M Weber Journal: J Gastrointest Surg Date: 2016-10-21 Impact factor: 3.452
Authors: Kevin B Ginsburg; Alberto A Castro Bigalli; Jared P Schober; David Perlman; Elizabeth A Handorf; David Y T Chen; Richard E Greenberg; Rosalia Viterbo; Robert G Uzzo; Alexander Kutikov; Marc C Smaldone; Andres F Correa Journal: Urol Oncol Date: 2022-06-17 Impact factor: 2.954
Authors: Olivia M Delozier; Zachary E Stiles; Benjamin W Deschner; Justin A Drake; Jeremiah L Deneve; Evan S Glazer; Miriam W Tsao; Danny Yakoub; Paxton V Dickson Journal: Ann Surg Oncol Date: 2020-07-11 Impact factor: 5.344